HomePARNF • OTCMKTS
add
Parnell Pharmaceuticals Holdings Ltd
Previous close
$0.00
Market cap
20.00 USD
Avg Volume
1.07K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | 2021info | Y/Y change |
|---|---|---|
Revenue | 34.17M | 13.88% |
Operating expense | 15.09M | 9.79% |
Net income | -1.42M | 90.57% |
Net profit margin | -4.16 | 91.71% |
Earnings per share | — | — |
EBITDA | 6.00M | 41.92% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | 2021info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.48M | 11.29% |
Total assets | 40.11M | -1.16% |
Total liabilities | 74.90M | 3.40% |
Total equity | -34.79M | — |
Shares outstanding | 29.62M | — |
Price to book | -0.00 | — |
Return on assets | 6.47% | — |
Return on capital | 9.18% | — |
Cash Flow
Net change in cash
| (AUD) | 2021info | Y/Y change |
|---|---|---|
Net income | -1.42M | 90.57% |
Cash from operations | 5.45M | 214.57% |
Cash from investing | -4.17M | -24.29% |
Cash from financing | 67.11K | -99.29% |
Net change in cash | 454.97K | 194.35% |
Free cash flow | -1.06M | 81.91% |
About
Founded
2009
Headquarters
Website
Employees
78
